A drug usually used for the treatment of multiple sclerosis appears to increase the activity of Nrf2, a protein that protects the body from oxidative stress and inflammation associated with Parkinson's disease.
A new study reports chronic lack of sleep and irregular sleep wake patterns may worsen motor and learning deficits bought on by Parkinson's disease.
A new study reports mice infected with a flu virus had an increased risk of developing Parkinson's symptoms. Importantly, mice vaccinated against the flu were less sensitive to MPTP and less likely to develop Parkinson's like symptoms.
Mitochondrial CYP2D6 may be a powerful target for the treatment of Parkinson's disease induced by MPTP.
With a new insight into a model of Parkinson’s disease, researchers have identified a novel target for mitigating some of the disease’s toll on the brain.
